They work on several fronts: they tell the brain to feel full sooner, they slow how fast the stomach empties, and they boost insulin release when glucose is high
In the realm of obesity treatment, two medications have emerged as promising options: tirzepatide and Semaglutide GLP-1
Ongoing support matters
Results from clinical trials suggest that such drugs could have potential for the treatment of asthma, which is one of the most chronic inflammatory pulmonary diseases in the world and often linked to both type 2 diabetes and obesity (Wu, Stokes Peebles)
A., Hussein, L., & Paliy, O
At 68 weeks (roughly 16 months), the STEP 1 trial showed average weight loss of 14.9% with semaglutide versus 2.4% with placebo